Oppenheimer & Co. Inc. Decreases Position in Stericycle Inc (SRCL)
Oppenheimer & Co. Inc. cut its stake in Stericycle Inc (NASDAQ:SRCL) by 17.2% during the third quarter, HoldingsChannel reports. The institutional investor owned 9,153 shares of the business services provider’s stock after selling 1,895 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Stericycle were worth $537,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. DnB Asset Management AS acquired a new stake in shares of Stericycle during the second quarter worth $692,000. IFM Investors Pty Ltd lifted its holdings in shares of Stericycle by 32.6% during the second quarter. IFM Investors Pty Ltd now owns 5,056 shares of the business services provider’s stock worth $330,000 after buying an additional 1,243 shares in the last quarter. Fulton Bank N.A. lifted its holdings in shares of Stericycle by 15.6% during the second quarter. Fulton Bank N.A. now owns 10,161 shares of the business services provider’s stock worth $663,000 after buying an additional 1,370 shares in the last quarter. Radnor Capital Management LLC acquired a new stake in shares of Stericycle during the second quarter worth $438,000. Finally, State of Alaska Department of Revenue lifted its holdings in shares of Stericycle by 14.6% during the second quarter. State of Alaska Department of Revenue now owns 20,540 shares of the business services provider’s stock worth $1,340,000 after buying an additional 2,620 shares in the last quarter. 95.11% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ SRCL opened at $48.56 on Thursday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.93. Stericycle Inc has a 52 week low of $45.55 and a 52 week high of $76.73. The firm has a market capitalization of $4.24 billion, a P/E ratio of 11.19, a P/E/G ratio of 1.21 and a beta of 0.52.
A number of research firms have recently weighed in on SRCL. Northcoast Research reissued a “neutral” rating on shares of Stericycle in a report on Friday, October 12th. BMO Capital Markets reissued a “hold” rating and set a $71.00 target price on shares of Stericycle in a report on Thursday, July 12th. BidaskClub downgraded Stericycle from a “sell” rating to a “strong sell” rating in a report on Wednesday. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a report on Monday, September 17th. Finally, Robert W. Baird dropped their target price on Stericycle from $70.00 to $56.00 and set a “neutral” rating for the company in a report on Friday, November 2nd. Five investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $65.38.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Featured Article: Trading Strategy Methods and Types
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.